EXOC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.494000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.497400E-01
Normal-vs-Stage2
9.949000E-01
Normal-vs-Stage3
3.156400E-01
Normal-vs-Stage4
4.989200E-01
Stage1-vs-Stage2
5.767800E-01
Stage1-vs-Stage3
3.463200E-01
Stage1-vs-Stage4
3.466800E-01
Stage2-vs-Stage3
1.862980E-01
Stage2-vs-Stage4
4.322000E-01
Stage3-vs-Stage4
1.846040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.574400E-01
Normal-vs-AfricanAmerican
7.582600E-01
Normal-vs-Asian
6.337200E-01
Caucasian-vs-AfricanAmerican
6.988000E-01
Caucasian-vs-Asian
4.225400E-01
AfricanAmerican-vs-Asian
8.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.405800E-01
Normal-vs-Female
9.582200E-01
Male-vs-Female
8.935200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.843000E-01
Normal-vs-Age(41-60Yrs)
7.370000E-01
Normal-vs-Age(61-80Yrs)
8.441000E-01
Normal-vs-Age(81-100Yrs)
6.967200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.958850E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.401800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.512600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.403600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.961210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.578200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.589800E-01
Normal-vs-Daily Drinker
9.618000E-01
Normal-vs-Weekly Drinker
8.713000E-01
Normal-vs-Occasional Drinker
7.752400E-01
Normal-vs-Social Drinker
8.094000E-01
Non Drinker-vs-Daily Drinker
2.299800E-01
Non Drinker-vs-Weekly Drinker
3.823000E-01
Non Drinker-vs-Occasional Drinker
4.385800E-02
Non Drinker-vs-Social Drinker
2.606000E-01
Daily Drinker-vs-Weekly Drinker
8.451600E-01
Daily Drinker-vs-Occasional Drinker
5.527800E-01
Daily Drinker-vs-Social Drinker
8.260000E-01
Weekly Drinker-vs-Occasional Drinker
4.417600E-01
Weekly Drinker-vs-Social Drinker
9.728400E-01
Occasional Drinker-vs-Social Drinker
3.519000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.786800E-01
Normal-vs-Grade 2
8.154000E-01
Normal-vs-Grade 3
3.170000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.884500E-03
Grade 1-vs-Grade 3
2.643600E-04
Grade 1-vs-Grade 4
9.786800E-01
Grade 2-vs-Grade 3
5.460500E-02
Grade 2-vs-Grade 4
8.154000E-01
Grade 3-vs-Grade 4
3.170000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.073600E-01
Normal-vs-NonDiabetic
9.195200E-01
Diabetic-vs-NonDiabetic
1.180230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.766400E-01
Normal-vs-NoPancreatitis
7.812400E-01
Pancreatitis-vs-NoPancreatitis
1.705630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.046600E-01
Normal-vs-N1
9.700200E-01
N0-vs-N1
3.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.288000E-01
Normal-vs-TP53-NonMutant
7.282200E-01
TP53-Mutant-vs-TP53-NonMutant
2.76259999998363E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
